Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Manufacturers requirement to report and maintain prescription drug prices
Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug
Prohibits a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug
Essential drugs; price increases; limits
Manufacturers prohibition from limiting pharmacy access to 340B drugs
Essential drugs; price increases; limits